DICE(Delisted)
DICE Therapeutics·NASDAQ
--
--(--)
DICE fundamentals
DICE Therapeutics (DICE) released its earnings on Nov 12, 2021: revenue was -- (YoY 0.00%), beat estimates; EPS was -- (YoY 0.00%), met estimates.
Revenue / YoY
--
0.00%
EPS / YoY
--
0.00%
Report date
Nov 12, 2021
EPS
Revenue
Revenue & Expenses
Key Indicators
DICE Therapeutics (DICE) key financial stats and ratios, covering profitability, financial health, and leverage.
DICE Therapeutics (DICE)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
DICE Therapeutics (DICE)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
DICE Therapeutics (DICE)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does DICE Therapeutics (DICE) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track DICE Therapeutics (DICE) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield
You can ask Aime
No Data
